Showing 1 - 10 of 55
I model optimal product-market competition policy when industriesdiffer inthe potential for quality-improving technological advance. In a two-periodmodel, a competition authority with limited resources administers adeterrence-based competition policy toward two industries. In one...
Persistent link: https://www.econbiz.de/10011303328
Persistent link: https://www.econbiz.de/10011754643
Persistent link: https://www.econbiz.de/10008695827
Persistent link: https://www.econbiz.de/10003862348
We introduce a cost of location into Hotelling’s (1929) spatial duopoly. We derive the general conditions on the cost-of-location function under which a pure strategy price-location Nash equilibrium exists. With linear transportation cost and a suitably specified cost of location that rises...
Persistent link: https://www.econbiz.de/10011257166
I model optimal product-market competition policy when industriesdiffer inthe potential for quality-improving technological advance. In a two-periodmodel, a competition authority with limited resources administers adeterrence-based competition policy toward two industries. In one...
Persistent link: https://www.econbiz.de/10011257346
We apply cross-sectional and panel data methods to a database of 5 million patients in 8,000 English general practices to examine whether better primary care management of 10 chronic diseases is associated with reduced hospital costs. We find that only primary care performance in stroke care is...
Persistent link: https://www.econbiz.de/10009294281
We examine conditions under which a platform ?rm can exclude rivals by bundling a product that some on one side of the market re- gard as essential with its platform, and pursue implications for market performance. We show that the impact of an exclusive dealing con- tract between the upstream...
Persistent link: https://www.econbiz.de/10008646756
In this paper, I compare economic arguments in U.S. Supreme Court antitrust and EU Court of Justice competition policy decisions on four topics: refusal to deal, predation, vertical contracts, and hor- izontal interfirm relations.
Persistent link: https://www.econbiz.de/10008728042
In this paper we develop a model of the impact of the drug approval process on the terms of a contract between a pharmaceutical company that requires the services of a contract research organization (CRO) to carry out testing of new drug molecules. Results show that if the equilibrium contract...
Persistent link: https://www.econbiz.de/10010862329